July 11, 2024
by Andrii Buvailo, PhD
Biopharma insight
Element Biosciences has raised over $277 million in a Series D funding round to further develop and commercialize its DNA …
June 27, 2024
by Andrii Buvailo
Biopharma insight
In 1986, Danish scientist Jens Juul Holst discovered that the gut hormone GLP-1 stimulates insulin and suppresses appetite. This research …
June 17, 2024
by Andrii Buvailo, PhD
News
Yonalink, a Boston-based provider of EHR-to-EDC streaming solutions for clinical trials, has announced the successful completion of its largest live …
June 10, 2024
by Roman Kasianov
News
BioStrand, a subsidiary of ImmunoPrecise Antibodies Ltd. (IPA), has launched its new LENSai API software, designed to integrate large databases …
May 14, 2024
by BiopharmaTrend
News
Recursion Pharmaceuticals has achieved a significant milestone by completing BioHive-2, reportedly the fastest supercomputer to be wholly owned and operated …
May 3, 2024
by Andrii Buvailo
Biopharma insight
The advent of artificial intelligence (AI) in healthcare has catalyzed an epoch of change, reshaping diagnostic procedures, therapeutic strategies, and …
April 29, 2024
by Louise von Stechow
Biopharma insight
Drug development for rare (also referred to as orphan) diseases is notoriously challenging. Legislative initiatives, such as the 1983 US …
April 18, 2024
by Andrii Buvailo, PhD
Interview
Sponsored by Trialize
In an industry as critical as clinical trials, where efficient data management and swift processes are paramount, outdated tech methods …
April 9, 2024
by Bohdana Sokolova
Biopharma insight
The world of clinical trials is undergoing an evolution as the rise of decentralized clinical trials (DCTs) brings about a change …
April 8, 2024
by Andrii Buvailo
Biopharma insight
Sponsored by Lantern Pharma
Clinical trials are the lifeline of modern medicine, bridging the gap between lab-borne scientific discoveries and the availability of life-saving …
April 3, 2024
by BiopharmaTrend
News
In a first-of-its kind analysis, BiopharmaTrend is excited to announce the release of its seminal report, "It’s Been a Decade …
March 19, 2024
by Andrii Buvailo, PhD
Biopharma insight
NVIDIA's CEO, Jensen Huang, recently outlined the company's expanded focus on software solutions designed to facilitate the adoption of artificial …